DOI: 10.1128/AAC.02169-17
Article Information
PubMed
Published By
History
- Received October 20, 2017
- Returned for modification November 17, 2017
- Accepted January 9, 2018
- Published online March 27, 2018.
Copyright & Usage
Copyright © 2018 American Society for Microbiology. All Rights Reserved.
Article Versions
- Accepted Manuscript version (January 16, 2018).
- You are viewing the most recent version of this article.
Author Information
- Hidetoshi Furuiea,
- Sayoko Taniokab,
- Keiko Shimizuc,
- Shigeru Manitac,
- Masaharu Nishimurad and
- Hisao Yoshidab
- aOsaka Pharmacology Clinical Research Hospital, Osaka, Japan
- bKyorin Pharmaceutical Co., Ltd., Tokyo, Japan
- cWatarase Research Center, Kyorin Pharmaceutical Co., Ltd., Tochigi, Japan
- dDepartment of Respiratory Medicine, Faculty of Medicine (and Graduate School of Medicine), Hokkaido University, Sapporo, Japan
- Address correspondence to Sayoko Tanioka, sayoko.tanioka{at}mb.kyorin-pharm.co.jp.
Citation Furuie H, Tanioka S, Shimizu K, Manita S, Nishimura M, Yoshida H. 2018. Intrapulmonary pharmacokinetics of lascufloxacin in healthy adult volunteers. Antimicrob Agents Chemother 62:e02169-17. https://doi.org/10.1128/AAC.02169-17.
